Moeller, S. J., Okita, K., Robertson, C. L., Ballard, M. E., Konova, A. B., Goldstein, R. Z., . . . London, E. D. (2018). Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users. Neuropsychopharmacology.

Moeller, Scott J., Kyoji Okita, Chelsea L. Robertson, Michael E. Ballard, Anna B. Konova, Rita Z. Goldstein, Mark A. Mandelkern, och Edythe D. London. "Low Striatal Dopamine D2-type Receptor Availability Is Linked to Simulated Drug Choice in Methamphetamine Users." Neuropsychopharmacology 2018.

Moeller, Scott J., et al. "Low Striatal Dopamine D2-type Receptor Availability Is Linked to Simulated Drug Choice in Methamphetamine Users." Neuropsychopharmacology 2018.